Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

503 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Activation of Human CD8+ T Cells with Nitroso Dapsone-Modified HLA-B*13:01-Binding Peptides.
Almutairi M, Lister A, Zhao Q, Line J, Adair K, Tailor A, Waddington J, Clarke E, Gardner J, Thomson P, Harper N, Sun Y, Sun L, Ostrov DA, Liu H, MacEwan DJ, Pirmohamed M, Meng X, Zhang F, Naisbitt DJ. Almutairi M, et al. J Immunol. 2023 Apr 15;210(8):1031-1042. doi: 10.4049/jimmunol.2200531. J Immunol. 2023. PMID: 36881872 Free PMC article.
Dapsone- and nitroso dapsone-specific activation of T cells from hypersensitive patients expressing the risk allele HLA-B*13:01.
Zhao Q, Alhilali K, Alzahrani A, Almutairi M, Amjad J, Liu H, Sun Y, Sun L, Zhang H, Meng X, Gibson A, Ogese MO, Kevin Park B, Liu J, Ostrov DA, Zhang F, Naisbitt DJ. Zhao Q, et al. Among authors: almutairi m. Allergy. 2019 Aug;74(8):1533-1548. doi: 10.1111/all.13769. Epub 2019 Apr 15. Allergy. 2019. PMID: 30844087 Free PMC article.
HLA Class-II‒Restricted CD8+ T Cells Contribute to the Promiscuous Immune Response in Dapsone-Hypersensitive Patients.
Zhao Q, Almutairi M, Tailor A, Lister A, Harper N, Line J, Meng X, Pratoomwun J, Jaruthamsophon K, Sukasem C, Sun Y, Sun L, Ogese MO, MacEwan DJ, Pirmohamed M, Liu J, Ostrov DA, Liu H, Zhang F, Naisbitt DJ. Zhao Q, et al. Among authors: almutairi m. J Invest Dermatol. 2021 Oct;141(10):2412-2425.e2. doi: 10.1016/j.jid.2021.03.014. Epub 2021 Mar 30. J Invest Dermatol. 2021. PMID: 33798536 Free article.
Navigating nephrology: unveiling pharmacist perspectives on renal dose adjustment in Saudi Arabia - a comprehensive cross-sectional analysis.
Alosaimi HM, Alwatban RA, Alshammari HM, Alshammari AH, Alanazi SS, Alreshidi MA, Alreshidi AA, Alsayed AS, Alfaraj FA, Alzayer KA, Alzaher AA, Almutairi KM, Almutairi MS, Aljasir RH, Alshammari MK. Alosaimi HM, et al. Among authors: almutairi ms. J Pharm Policy Pract. 2024 May 22;17(1):2344223. doi: 10.1080/20523211.2024.2344223. eCollection 2024. J Pharm Policy Pract. 2024. PMID: 38798764 Free PMC article.
503 results